Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
Primary Care
How do you approach treatment intensification in patients with RA and low disease activity but not in remission, considering the potential risks of increased immunosuppression?
Related Questions
What is your approach to work up for patients referred for early onset osteoarthritis?
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
Are you comfortable trying a different JAK inhibitor in patients with prior JAK inhibitor allergy?
What is your treatment approach for a young female who has an idiopathic small right elbow effusion with synovial thickening that has resulted in limitation in her range of motion?
What is your approach to monitoring patients referred for high titer +RF and +CCP but without active symptoms of inflammatory arthritis?
How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?
How do you approach medication management in patients with RA when transitioning from csDMARD triple therapy to anti-TNF?
Are you comfortable with using NSAIDs in a patient on methotrexate for inflammatory arthritis?
How would you approach management of a young male patient with discoid lupus who has had minimal response to hydroxychloroquine (and subtherapeutic whole blood levels) who continues to use tobacco products?
Does the presence of calcified granulomas on chest imaging influence your choice of biologic for treatment of psoriatic arthritis (or rheumatoid arthritis)?
